One of our guest we bring you in this episode is a self-described industry dinosaur. The reason he can make a claim like that, of course, is his longevity. But also, perhaps without knowing it, he can make that claim because of the long-term impact he has had on health care. In fact, if you look back over the past 30 years of pharmaceuticals, you can see his fingerprints on so many of the advancements that we take for granted today. This dinosaur is Steve Aselage. He is a member of the board of directors of Travere Therapeutics where he previously was CEO.
He is joined on this episode by his daughter, Beth Aselage, Associate Director of Advocacy Relations for Gossamer Bio. Beth speaks with a wisdom that combines analytical insights with an abiding desire to advocate on behalf of patients. She has a unique ability to harvest what is most important to patients and to fuse them into an ongoing development for pharmaceutical companies.
Of course the insight that they offer is second-to-none. However, we wanted to bring you the two of them together for an even bigger reason. We wanted you to know about the depth of the legacy that a passion for serving patients can have. When that passion is more than just a saying, patient-first mentalities have the power to change our industry for years to come.
Please subscribe and keep listening to Rare Voices!
Music Credits:
Westpoint Instrumental by Sun Shapes
Rare Voices reveals the wisest path to a fulfilled life for patients with rare and orphan disorders. Brought to you by the people at Optime Care, a pioneering specialty pharmacy. In each episode, we uncover insights from patient advocates, pharmaceutical innovators, leaders in insurance, physicians, and caregivers. Prepare to provoke your mind and fuel your drive to serve rare and orphan patient populations.